CME Group Challenges CFTC Over Kalshi's Perpetual Futures Approval
In a significant legal move, CME Group has filed a lawsuit against the CFTC, contesting the agency's approval of Kalshi's inaugural U.S. perpetual futures product.
Editorial Staff
1 min read
Updated 4 days ago
CME Group has taken legal action against the Commodity Futures Trading Commission (CFTC), asserting that the agency made an error in its approval process for Kalshi's first U.S. perpetual futures product.
This lawsuit, filed on Thursday, raises questions about the regulatory framework surrounding perpetual futures and their classification.
The outcome of this case could have implications for the future of trading in perpetual futures within the U.S. market.